TRANSDERMAL SCOPOLAMINE FOR REDUCTION OF DROOLING IN DEVELOPMENTALLY DELAYED CHILDREN
- 1 June 1994
- journal article
- clinical trial
- Published by Wiley in Developmental Medicine and Child Neurology
- Vol. 36 (6) , 484-486
- https://doi.org/10.1111/j.1469-8749.1994.tb11877.x
Abstract
Ten developmentally delayed children with excessive drooling were randomized in a double-blind, placebo-controlled study to assess the efficacy and safety of transdermal scopolamine. Over half of the patients had a statistically significant reduction in drooling, and one-third had cessation of drooling, while wearing the scopolamine patch. This short-term study supports earlier reports of the safety and efficacy of transdermal scopolamine for reducing excessive drooling in developmentally disabled children.Keywords
This publication has 4 references indexed in Scilit:
- DROOLING IN THE DEVELOPMENTAL DISABLED: MANAGEMENT PRACTICES AND RECOMMENDATIONSDevelopmental Medicine and Child Neurology, 1992
- Control of Drooling with Transdermal Scopolamine in a Child with Cerebral PalsyDevelopmental Medicine and Child Neurology, 1991
- Scopolamine patch reduces postoperative emesis in paediatric patients following strabismus surgeryCanadian Journal of Anesthesia/Journal canadien d'anesthésie, 1991
- Reduction of salivary flow with transdermal scopolamine: A four‐year experienceOtolaryngology -- Head and Neck Surgery, 1990